Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Leiomyosarcoma Uterus × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 463 Glioblastoma 163 Gliosarcoma 162 Osteosarcoma 139 Dendritic Cell Sarcoma, Interdigitating 102 Brain Neoplasms 102 Gastrointestinal Stromal Tumors 100 Central Nervous System Neoplasms 94 Glioma 74 Rhabdomyosarcoma 73 Lymphoma, Non-Hodgkin 72 Burkitt Lymphoma 71 Lymphoma 69 Recurrence 67 Precursor Cell Lymphoblastic Leukemia-Lymphoma 66 Leiomyosarcoma 66 Lymphoma, Large B-Cell, Diffuse 63 Sarcoma, Ewing 61 Astrocytoma 61 Liposarcoma 60 Lymphoma, Follicular 57 Neuroblastoma 56 Lymphoma, Mantle-Cell 52 Leukemia, Lymphocytic, Chronic, B-Cell 51 Lymphoma, B-Cell, Marginal Zone 50 Neuroectodermal Tumors, Primitive, Peripheral 49 Leukemia, Myeloid, Acute 49 Lymphoma, Large-Cell, Immunoblastic 48 Hodgkin Disease 48 Sarcoma, Kaposi 45

Interventions

Trabectedin 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06524583 2025-03-30

L-UteCIN

UNICANCER

Phase 2 Recruiting

Leiomyosarcoma Uterus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡